OptiRTP CEO Jon Doherty presented the company’s Optimum Bio Sound Therapy (OBST) platform to a Utah state delegation led by Governor Spencer J. Cox at an AmCham business briefing held during Auckland Start-Up Week on 20 October 2025.

The delegation included more than 60 senior representatives from Utah’s business, innovation, higher education, and government sectors—one of the largest U.S. state delegations to visit New Zealand.

The presentation covered OptiRTP’s planned U.S. operational headquarters, its clinical validation program being developed under the CMS “Coverage with Evidence Development” framework, and progress toward FDA Class II registration.

Following the briefing, CEO Jon Doherty and Founder & CTO Bogdan Anich met with representatives from Bank of America, the University of Utah, and other Utah-based organisations to discuss potential support for OptiRTP’s U.S. establishment.

Utah is one of several states OptiRTP will visit in Q1 2026 as part of its U.S. site selection process.